Yorktown Management & Research Company’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,100
Closed -$272K 200
2024
Q1
$272K Hold
4,100
0.26% 189
2023
Q4
$403K Hold
4,100
0.42% 96
2023
Q3
$328K Buy
4,100
+1,400
+52% +$110K 0.37% 120
2023
Q2
$218K Hold
2,700
0.23% 186
2023
Q1
$328K Hold
2,700
0.35% 121
2022
Q4
$360K Hold
2,700
0.44% 101
2022
Q3
$301K Hold
2,700
0.39% 105
2022
Q2
$366K Hold
2,700
0.47% 92
2022
Q1
$450K Hold
2,700
0.38% 111
2021
Q4
$482K Hold
2,700
0.33% 131
2021
Q3
$478K Hold
2,700
0.36% 115
2021
Q2
$434K Hold
2,700
0.34% 128
2021
Q1
$404K Hold
2,700
0.34% 103
2020
Q4
$266K Buy
+2,700
New +$270K 0.24% 181

Other funds holding CNXC

Yorktown Management & Research Company's CNXC Position: Q2 2024 in Review

Yorktown Management & Research Company sold out of Concentrix (CNXC) in Q2 2024, closing a stake of 4,100 shares — an estimated $272K sold.

Yorktown Management & Research Company first reported a position in CNXC in Q4 2020 and held it in 14 quarters. The position peaked at $482K in Q4 2021. 297 funds tracked by Wall St. Rank hold CNXC as of Q2 2024.

  • Yorktown Management & Research Company reported no remaining Concentrix position as of Q2 2024 after selling out during the quarter.
  • Yorktown Management & Research Company sold 4,100 Concentrix shares in Q2 2024, an estimated $272K.
  • Yorktown Management & Research Company first reported a position in Concentrix in Q4 2020 and held it in 14 quarters.
  • Yorktown Management & Research Company's Concentrix position peaked at $482K in Q4 2021.
  • 297 funds tracked by Wall St. Rank held Concentrix as of Q2 2024.

Based on Yorktown Management & Research Company's 13F filing for Q2 2024, filed 30 Jul 2024.